Intrauterine growth restriction
- 1 April 2002
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Obstetrics and Gynecology
- Vol. 14 (2) , 127-135
- https://doi.org/10.1097/00001703-200204000-00005
Abstract
Pathophysiological processes underlying intrauterine growth restriction are very complex and poorly understood. Growth restricted fetuses are at risk of hypoxia and, therefore, an early diagnosis of intrauterine growth restriction is important for initiation of fetal surveillance. Application of a three-dimensional ultrasound method for estimation of fetal weight promises better precision. Use of conditional standard deviation scores of fetal biometric variables has been suggested for improved individualized evaluation of intrauterine growth. Application of umbilical artery Doppler velocimetry in the clinical management of growth-restricted fetuses after 32 weeks of gestation leads to decreased perinatal mortality and lower rates of obstetric interventions. Evaluation of fetal state before 32 weeks is difficult and should include Doppler examination of placental circulation and several fetal arterial and venous vessel beds. In addition, recordings of short-term variability of fetal heart rate and biophysical profile have been suggested for fetal surveillance. Important new data on the time sequence of Doppler changes in various vessels of compromised very preterm growth restricted fetuses have been presented, which will enable the establishment of clinical management protocols for evaluation in prospective randomized studies.Keywords
This publication has 57 references indexed in Scilit:
- Combined heterozygosity for methylenetetrahydrofolate reductase (MTHFR) mutations C677T and A1298C is associated with abruptio placentae but not with intrauterine growth restrictionEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2001
- Intrauterine Growth Restriction Without Pre-eclampsia and Associated Changes in Serum Inhibin A and Activin A Levels: a Case ReportPlacenta, 2001
- Fetal hemoglobin-expressing nucleated red blood cell frequencies in pregnancies with intrauterine growth restrictionPrenatal Diagnosis, 2001
- Neutrophil activation in preeclampsia and isolated intrauterine growth restrictionAmerican Journal of Obstetrics and Gynecology, 2000
- Size at Birth and Cord Blood Levels of Insulin, Insulin-Like Growth Factor I (IGF-I), IGF-II, IGF-Binding Protein-1 (IGFBP-1), IGFBP-3, and the Soluble IGF-II/Mannose-6-Phosphate Receptor in Term Human InfantsJournal of Clinical Endocrinology & Metabolism, 2000
- Second-trimester plasma homocysteine levels and pregnancy-induced hypertension, preeclampsia, and intrauterine growth restrictionAmerican Journal of Obstetrics and Gynecology, 2000
- Disturbed Feto-Maternal Cell Traffic in PreeclampsiaPublished by Wolters Kluwer Health ,2000
- Maternal insulin-like growth factor binding protein-1, body mass index, and fetal growthArchives of Disease in Childhood: Fetal & Neonatal, 2000
- The relationship of the levels of leptin, insulin-like growth factor-I and insulin in cord blood with birth size, ponderal index, and gender difference.Journal of Pediatric Endocrinology and Metabolism, 2000
- Folic Acid and Homocyst(e)ine Metabolic Defects and the Risk of Placental Abruption, Pre-eclampsia and Spontaneous Pregnancy Loss: A Systematic ReviewPlacenta, 1999